Hoofnagle JH - Search Results

1

A randomized, double-blind, placebo-controlled trial of recombinant human alpha-interferon therapy for chronic non-A, non-B (type C) hepatitis.

Di Bisceglie AM, Martin P, Kassianides C, Lisker-Melman M, Goodman Z, Banks SM, Hoofnagle JH. Di Bisceglie AM, et al. Among authors: hoofnagle jh. J Hepatol. 1990;11 Suppl 1:S36-42. doi: 10.1016/0168-8278(90)90161-j. J Hepatol. 1990. PMID: 2127786 Clinical Trial.

2

A pilot study of ribavirin therapy for chronic hepatitis C.

Di Bisceglie AM, Shindo M, Fong TL, Fried MW, Swain MG, Bergasa NV, Axiotis CA, Waggoner JG, Park Y, Hoofnagle JH. Di Bisceglie AM, et al. Among authors: hoofnagle jh. Hepatology. 1992 Sep;16(3):649-54. doi: 10.1002/hep.1840160307. Hepatology. 1992. PMID: 1505907

3

Acute exacerbation of liver disease during interferon alfa therapy for chronic hepatitis C.

Shindo M, Di Bisceglie AM, Hoofnagle JH. Shindo M, et al. Among authors: hoofnagle jh. Gastroenterology. 1992 Apr;102(4 Pt 1):1406-8. Gastroenterology. 1992. PMID: 1551549

4

Measurements of iron status in patients with chronic hepatitis.

Di Bisceglie AM, Axiotis CA, Hoofnagle JH, Bacon BR. Di Bisceglie AM, et al. Among authors: hoofnagle jh. Gastroenterology. 1992 Jun;102(6):2108-13. doi: 10.1016/0016-5085(92)90339-z. Gastroenterology. 1992. PMID: 1587431

5

Development of thyroid disease during therapy of chronic viral hepatitis with interferon alfa.

Lisker-Melman M, Di Bisceglie AM, Usala SJ, Weintraub B, Murray LM, Hoofnagle JH. Lisker-Melman M, et al. Among authors: hoofnagle jh. Gastroenterology. 1992 Jun;102(6):2155-60. doi: 10.1016/0016-5085(92)90348-3. Gastroenterology. 1992. PMID: 1587439

6

The significance of antibody to hepatitis C virus in patients with chronic hepatitis B.

Fong TL, Di Bisceglie AM, Waggoner JG, Banks SM, Hoofnagle JH. Fong TL, et al. Among authors: hoofnagle jh. Hepatology. 1991 Jul;14(1):64-7. doi: 10.1002/hep.1840140111. Hepatology. 1991. PMID: 1648540

7

Chronic fatigue syndrome: lack of association with hepatitis C virus infection.

Dale JK, Di Bisceglie AM, Hoofnagle JH, Straus SE. Dale JK, et al. Among authors: hoofnagle jh. J Med Virol. 1991 Jun;34(2):119-21. doi: 10.1002/jmv.1890340209. J Med Virol. 1991. PMID: 1653818

8

Decrease in serum hepatitis C viral RNA during alpha-interferon therapy for chronic hepatitis C.

Shindo M, Di Bisceglie AM, Cheung L, Shih JW, Cristiano K, Feinstone SM, Hoofnagle JH. Shindo M, et al. Among authors: hoofnagle jh. Ann Intern Med. 1991 Nov 1;115(9):700-4. doi: 10.7326/0003-4819-115-9-700. Ann Intern Med. 1991. PMID: 1656828 Clinical Trial.

9

Long-term clinical and histopathological follow-up of chronic posttransfusion hepatitis.

Di Bisceglie AM, Goodman ZD, Ishak KG, Hoofnagle JH, Melpolder JJ, Alter HJ. Di Bisceglie AM, et al. Among authors: hoofnagle jh. Hepatology. 1991 Dec;14(6):969-74. doi: 10.1016/0270-9139(91)90113-a. Hepatology. 1991. PMID: 1959884

10

Long-term remission of chronic hepatitis B after alpha-interferon therapy.

Korenman J, Baker B, Waggoner J, Everhart JE, Di Bisceglie AM, Hoofnagle JH. Korenman J, et al. Among authors: hoofnagle jh. Ann Intern Med. 1991 Apr 15;114(8):629-34. doi: 10.7326/0003-4819-114-8-629. Ann Intern Med. 1991. PMID: 2003708

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

531 results

Search Page

Filters